PMID: 11927843Apr 3, 2002Paper

Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years

Pharmacogenetics
Shan Wang-GohrkeJenny Chang-Claude

Abstract

We used a large population-based case-control study to determine whether three known p53 polymorphisms, intron 3 16 bp duplication, codon 72(Arg/Pro) and intron 6 MspI restriction fragment length polymorphism, alter the risk for breast cancer in German women. For all three polymorphisms, the odds ratios (ORs) for breast cancer were increased in women carrying the rare allele; however, this was statistically significant only for the 16 bp duplication polymorphism. Compared with the 16 bp duplication wild-type A1/A1 genotype, ORs for A1/A2 genotype and A2/A2 genotype were 1.3 [95% confidence interval (CI) 1.0-1.7] and 1.7 (95% CI 0.8-3.4), suggesting an allele dosage effect (trend test, P = 0.03). Significant evidence was found for a differential effect by family history of breast cancer (P = 0.03 for interaction), with the OR being 5.3 among women with a first degree family history. Our data suggest that inheritance of an intronic polymorphism in the p53 gene increases breast cancer risk appreciably in women by the age of 50 years with a family history of breast cancer in the German population.

References

Feb 10, 1996·Lancet·I G CampbellV Leake
Jun 1, 1996·Carcinogenesis·A SjälanderL Beckman
Mar 4, 1998·British Journal of Cancer·D MavridouD M Eccles
Apr 18, 1998·Cancer Genetics and Cytogenetics·A WestonA Morabia
Nov 7, 2000·Cancer Causes & Control : CCC·J Chang-ClaudeH Becher

❮ Previous
Next ❯

Citations

Dec 10, 2002·International Journal of Cancer. Journal International Du Cancer·Evgeny N SuspitsinEvgeny N Imyanitov
Jan 18, 2005·Molecular Genetics and Genomics : MGG·A V KhruninS A Limborska
Jul 25, 2009·Breast Cancer Research and Treatment·Zhizhong ZhangZhengdong Zhang
Aug 7, 2009·Breast Cancer Research and Treatment·Zheng HuLi Su
May 6, 2010·Medical Oncology·Shafika AlawadiMoussa Alkhalaf
Dec 3, 2008·Pathology Oncology Research : POR·Mustafa AkkiprikAyse Ozer
Oct 5, 2006·Journal of the National Cancer Institute·UNKNOWN Breast Cancer Association Consortium
Apr 16, 2009·Genetics in Medicine : Official Journal of the American College of Medical Genetics·A Cecile J W JanssensCornelia M van Duijn
Dec 30, 2004·Journal of Clinical Pathology·S MitraS Roychoudhury
Dec 3, 2008·BMC Cancer·Juliana G AssumpçãoJosé Andres Yunes
Aug 18, 2009·Journal of Experimental & Clinical Cancer Research : CR·Wenlei ZhuoZhengtang Chen
Jun 26, 2004·Breast Cancer Research : BCR·Karen G MontgomeryIan G Campbell
Dec 20, 2003·Pharmacogenomics·Stella C LymberisSilvia C Formenti
Jun 2, 2012·North American Journal of Medical Sciences·B LajinSakur A Alhaj
Sep 17, 2014·BMC Cancer·Marta Winiecka-KlimekEwelina Stoczynska-Fidelus
Dec 7, 2005·Breast Cancer Research and Treatment·Xiang-Lin TanJenny Chang-Claude
Mar 9, 2007·DNA Sequence : the Journal of DNA Sequencing and Mapping·Fabio BottariFederica Gemignani
Feb 9, 2008·Cancer Investigation·Laura BoldriniGabriella Fontanini
Nov 19, 2004·Neoplasia : an International Journal for Oncology Research·Regine Schneider-StockAlbert Roessner
Apr 7, 2010·Cancer Genetics and Cytogenetics·Emina J MalisicSinisa S Radulovic
Dec 15, 2015·Mutation Research. Genetic Toxicology and Environmental Mutagenesis·Nikolai V LitviakovАndrei B Karpov
Jun 28, 2005·International Journal of Cancer. Journal International Du Cancer·Sayan MitraSusanta Roychoudhury
Aug 9, 2007·International Journal of Cancer. Journal International Du Cancer·Montserrat Garcia-ClosasStephen Chanock
Aug 11, 2007·American Journal of Human Biology : the Official Journal of the Human Biology Council·Andrey KhruninSvetlana Limborska
Apr 26, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Nasser PouladiDavoud Farajzadeh
Sep 22, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Kamlesh GuleriaVasudha Sambyal
Apr 16, 2013·BioMed Research International·Igor Brasil-CostaAndrea K C Ribeiro-dos-Santos
Sep 6, 2007·Neoplasia : an International Journal for Oncology Research·Nikola HoltkampAndreas von Deimling
Sep 10, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Chaymaa MaroufSellama Nadifi
Jul 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carey K AndersKimberly L Blackwell
May 24, 2011·Breast Cancer Research and Treatment·Xiao-Feng HeK Arparkorn
Jun 6, 2013·Experimental and Therapeutic Medicine·Jing HouShuting Jia
Aug 30, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Sarika SharmaArun Gupta
Oct 24, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Sukhpreet KaurHarpreet Singh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.